Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Successful Long- Term Outcome and Chimeric Status Following Allogeneic Stem Cell Transplantation for Non-Malignant Disorders Using Moderate T Cell Depletion with No Post Transplant Gvhd Prophylaxis.

Ronit Elhasid, MD, Irina Zaidman, MD, Khalil Abdalla, MD, Miriam Ben-Arush, MD, Nuhad Haddad, MD, Tsila Zuckerman, MD, Osnat Gidoni, Dina Rubin, Rina Katz, Shimon Polack, MD, Yair Reisner, Ph.D, Jacob M. Rowe, MD

Blood (2008) 112 (11): 3292.

https://doi.org/10.1182/blood.V112.11.3292.3292

Published: 2008

Journal Articles

Pharmacological Therapy of Inherited Disease.

Jeffrey R. Keefer, MD, PhD, Martina C. McGuinness, PhD, Gao X. Dong, PhD, George J. Dover, MD, Kirby D. Smith, PhD

Blood (2005) 106 (11): 3179.

https://doi.org/10.1182/blood.V106.11.3179.3179

Published: 2005

Journal Articles

Treosulfan-Based Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Increased Risk of Conventional Regimen Toxicity.

Jacek Wachowiak, Alicja Chybicka, Jerzy Kowalczyk, Grzegorz Grund, Dariusz Boruczkowski, Ewa Gorczynska, Beata Wojcik, Michal Leda, Dominik Turkiewicz, Katarzyna Drabko

Blood (2005) 106 (11): 1761.

https://doi.org/10.1182/blood.V106.11.1761.1761

Published: 2005

Journal Articles

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer

Ugo Ramenghi, Sara Bonissoni, Giuseppe Migliaretti, Simona DeFranco, Flavia Bottarel, Caterina Gambaruto, Daniela DiFranco, Roberta Priori, Fabrizio Conti, Irma Dianzani, Guido Valesini, Franco Merletti, Umberto Dianzani

Blood (2000) 95 (10): 3176–3182.

https://doi.org/10.1182/blood.V95.10.3176

Published: 2000

Journal Articles

Deficiency of the Fas Apoptosis Pathway Without Fas Gene Mutations in Pediatric Patients With Autoimmunity/Lymphoproliferation

Umberto Dianzani, Manuela Bragardo, Daniela DiFranco, Carla Alliaudi, Paola Scagni, Donatella Buonfiglio, Valter Redoglia, Sara Bonissoni, Antonio Correra, Irma Dianzani, Ugo Ramenghi

Blood (1997) 89 (8): 2871–2879.

https://doi.org/10.1182/blood.V89.8.2871

Published: 1997

NARROW

Successful Long- Term Outcome and Chimeric Status Following Allogeneic Stem Cell Transplantation for Non-Malignant Disorders Using Moderate T Cell Depletion with No Post Transplant Gvhd Prophylaxis.

Pharmacological Therapy of Inherited Disease.

Treosulfan-Based Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Increased Risk of Conventional Regimen Toxicity.

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer

Deficiency of the Fas Apoptosis Pathway Without Fas Gene Mutations in Pediatric Patients With Autoimmunity/Lymphoproliferation

Email alerts

ASH Publications

American Society of Hematology

Successful Long- Term Outcome and Chimeric Status Following Allogeneic Stem Cell Transplantation for Non-Malignant Disorders Using Moderate T Cell Depletion with No Post Transplant Gvhd Prophylaxis.

Pharmacological Therapy of Inherited Disease.

Treosulfan-Based Preparative Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Increased Risk of Conventional Regimen Toxicity.

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer

Deficiency of the Fas Apoptosis Pathway Without Fas Gene Mutations in Pediatric Patients With Autoimmunity/Lymphoproliferation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only